UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro

Scientific reports, 2022-07, Vol.12 (1), p.12493-12493, Article 12493

2022

Volltextzugriff (PDF)

Impairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A165 No Longer Depends on the Growth Factor’s Presence

Biomolecules (Basel, Switzerland), 2022-05, Vol.12 (5), p.734

2022

Volltextzugriff (PDF)

Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders

PloS one, 2016, Vol.11 (1), p.e0145375

2016

Volltextzugriff (PDF)

Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure

Journal of Diabetes Research, 2020, Vol.2020, p.2450781-16

2020

Volltextzugriff (PDF)

VEGFA165‐induced persistent impairment of the retinal endothelial cells' barrier only transiently depends on the growth factor's action

Acta ophthalmologica (Oxford, England), 2022-12, Vol.100 (S275), p.n/a

2022

Volltextzugriff (PDF)

Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165

Cellular physiology and biochemistry, 2017, Vol.42 (4), p.1493-1513

2017

Volltextzugriff (PDF)

Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells

Experimental eye research, 2022-03, Vol.216, p.108945-108945, Article 108945

2022

Volltextzugriff (PDF)

Type of culture medium determines properties of cultivated retinal endothelial cells: induction of substantial phenotypic conversion by standard DMEM

Heliyon, 2021-01, Vol.7 (1), p.e06037-e06037, Article e06037

2021

Volltextzugriff (PDF)

Transport and fate of aflibercept in VEGF-A165-challenged retinal endothelial cells

Experimental eye research, 2020-09, Vol.198, p.108156, Article 108156

2020

Volltextzugriff (PDF)

Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells

Experimental eye research, 2014-05, Vol.122, p.20-31

2014

Volltextzugriff (PDF)

VEGF but not PlGF disturbs the barrier of retinal endothelial cells

Experimental eye research, 2013-10, Vol.115, p.162-171

2013

Volltextzugriff (PDF)

VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells

Experimental eye research, 2020-05, Vol.194, p.108004-108004, Article 108004

2020

Volltextzugriff (PDF)

Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences

British journal of ophthalmology, 2012-07, Vol.96 (7), p.1023-1028

2012

Volltextzugriff (PDF)

Internalization of bevacizumab by retinal endothelial cells and its intracellular fate: Evidence for an involvement of the neonatal Fc receptor

Experimental eye research, 2016-02, Vol.143, p.49-59

2016

Volltextzugriff (PDF)

Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation

Graefe's archive for clinical and experimental ophthalmology, 2019-01, Vol.257 (1), p.83-94

2019

Volltextzugriff (PDF)

Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses

Genetics and molecular biology, 2012-01, Vol.35 (1), p.53-56

2012

Volltextzugriff (PDF)

Neonatal Fc receptor FcRn is involved in intracellular transport of the Fc fusion protein aflibercept and its transition through retinal endothelial cells

Experimental eye research, 2017-01, Vol.154, p.39-46

2017

Volltextzugriff (PDF)

Different responses of the MIO‑M1 Mueller cell line to angiotensin II under hyperglycemic or hypoxic conditions

Biomedical reports, 2023-09, Vol.19 (3), p.1-62, Article 62

2023

Volltextzugriff (PDF)

Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A 165

Cellular physiology and biochemistry, 2017-10, Vol.42 (4), p.1493-1513

2017

Volltextzugriff (PDF)

Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells

Graefe's archive for clinical and experimental ophthalmology, 2013-10, Vol.251 (10), p.2345-2353

2013

Volltextzugriff (PDF)

Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells

British journal of ophthalmology, 2011-08, Vol.95 (8), p.1151-1156

2011

Volltextzugriff (PDF)

Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells

Graefe's archive for clinical and experimental ophthalmology, 2015-06, Vol.253 (6), p.885-894

2015

Volltextzugriff (PDF)

Inhibition of Protein Kinase C Is Not Sufficient to Prevent or Reverse Effects of VEGF165 on Claudin-1 and Permeability in Microvascular Retinal Endothelial Cells

Investigative ophthalmology & visual science, 2010-01, Vol.51 (1), p.535-542

2010

Volltextzugriff (PDF)

VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells

Experimental eye research, 2024-08, p.110062

2024

Volltextzugriff (PDF)

The Protein Kinase C Inhibitor: Ruboxistaurin

Developments in ophthalmology, 2016, Vol.55, p.295

2016

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)
Buchkapitel
(1)

Sprache

Englisch
(30)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Retinal Endothelial Cells
(16)
Animals
(14)
Life Sciences & Biomedicine
(14)
Cattle
(13)
Ophthalmology
(12)
Endothelial Cells - Metabolism
(10)
Permeability
(10)
Vascular Endothelial Growth Factor
(10)
Diabetic Retinopathy
(9)
Blotting, Western
(8)
Retina
(8)
Retinal Vessels - Cytology
(8)
Vascular Endothelial Growth Factor A - Pharmacology
(8)
Diabetes
(7)
Endothelial Cells - Drug Effects
(7)
Humans
(7)
Proteins
(7)
Ranibizumab
(7)
Aflibercept
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro

Impairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A165 No Longer Depends on the Growth Factor’s Presence

Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders

Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure

VEGFA165‐induced persistent impairment of the retinal endothelial cells' barrier only transiently depends on the growth factor's action

Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165

Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells

Type of culture medium determines properties of cultivated retinal endothelial cells: induction of substantial phenotypic conversion by standard DMEM

Transport and fate of aflibercept in VEGF-A165-challenged retinal endothelial cells

Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells

VEGF but not PlGF disturbs the barrier of retinal endothelial cells

VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells

Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences

Internalization of bevacizumab by retinal endothelial cells and its intracellular fate: Evidence for an involvement of the neonatal Fc receptor

Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation

Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses

Neonatal Fc receptor FcRn is involved in intracellular transport of the Fc fusion protein aflibercept and its transition through retinal endothelial cells

Different responses of the MIO‑M1 Mueller cell line to angiotensin II under hyperglycemic or hypoxic conditions

Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A 165

Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells

Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells

Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells

Inhibition of Protein Kinase C Is Not Sufficient to Prevent or Reverse Effects of VEGF165 on Claudin-1 and Permeability in Microvascular Retinal Endothelial Cells

VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells

The Protein Kinase C Inhibitor: Ruboxistaurin

Suchergebnisse filtern